Brief: Selvita To Expand Its Operations Through New Biological Drug Business

Selvita SA

18/03/2024 06:58

March 18 (Reuters) - Selvita SA  SLV1.WA :
    * RESOLVES TO EXPAND ITS OPERATIONS THROUGH INTRODUCTION OF
NEW
TYPE OF SERVICES RELATED TO BIOLOGIC DRUG DISCOVERY AND
DEVELOPMENT
    * SELVITA SA SAYS NEW BIOLOGICAL DRUG BUSINESS WILL ALLOW
COMPANY
TO ADDRESS SECOND LARGEST CHUNK OF DRUG DISCOVERY MARKET AFTER
SMALL-MOLECULE DRUGS
    * UNDER EXPANSION PLAN COMPANY SIGNED 2.0 MILLION ZLOTY NET
DEAL
WITH PURE BIOLOGICS FOR PURCHASE OF LABORATORY EQUIPMENT
    * UNDER EXPANSION PLAN COMPANY SIGNED CONDITIONAL 5-YEAR
LEASE
AGREEMENT FOR APPROX. 430 SQM LABORATORY SPACE
    * DEAL INCLUDES POSSIBILITY OF INCREASING LABORATORY SPACE
IN 
FUTURE TO A TOTAL OF ABOUT 800 SQM THIS COULD CREATE JOBS FOR
ABOUT 50 SPECIALISTS
    * UNDER EXPANSION PLAN COMPANY ALSO SIGNED LETTERS OF INTENT
WITH
16 HIGH-LEVEL BIOLOGICAL DRUG DEVELOPMENT SPECIALISTS

Source text for Eikon:  urn:newsml:reuters.com:*:nEMbrpvYNa
Further company coverage:  SLV1.WA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))